# Intravenous Tenecteplase Plus EVT Versus EVT Alone on 4.5 to 24 Hours After Basilar Artery Occlusion

> **NCT05701956** · PHASE3 · COMPLETED · sponsor: **The First Affiliated Hospital of University of Science and Technology of China** · enrollment: 330 (actual)

## Conditions studied

- Basilar Artery Occlusion
- Acute Cerebrovascular Accident
- Stroke Due to Basilar Artery Occlusion

## Interventions

- **DRUG:** Tenecteplase
- **PROCEDURE:** Endovascular thrombectomy

## Key facts

- **NCT ID:** NCT05701956
- **Lead sponsor:** The First Affiliated Hospital of University of Science and Technology of China
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-16
- **Primary completion:** 2025-02-04
- **Final completion:** 2025-05-04
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05701956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05701956, "Intravenous Tenecteplase Plus EVT Versus EVT Alone on 4.5 to 24 Hours After Basilar Artery Occlusion". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05701956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*